Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>News

  News Archive

Guided Chemotherapy Missiles to Target Cancer Cells
Tuesday, July 05, 2016
Latching chemotherapy drugs onto proteins that seek out tumors could provide a new way of treating tumors in the brain or with limited blood supply that are hard to reach with traditional chemotherapy.

Unsilencing Silenced Genes by CRISPR/Cas9
Tuesday, July 05, 2016
Scientists at Hokkaido University in Japan developed a new technique to unleash silenced genes and change cell fates using CRISPR/Cas9.

Cancer Research UK joins forces with U.S. 'Cancer Moonshot'
Monday, July 04, 2016
Cancer Research UK and the US government’s National Cancer Institute have announced that two teams will work together to radically accelerate progress against cancer, in one of the first international collaborations inspired by US Vice President Joe Biden’s Cancer Moonshot.

Accuray Receives FDA Clearance
Saturday, July 02, 2016
Company has received FDA clearance for the Radixact™ image-guided radiation therapy platform and integrated software.

CGI Receives NY State Approval for NGS Lymphoma Panel
Saturday, July 02, 2016
This approval is a testament to CGI’s ability to provide NGS panels that meet the highest quality standards.

Omniseq Receives New York CLEP Approval
Saturday, July 02, 2016
Company has received NY State CLEP approval for its ComprehensiveSM panel, a 144 gene, pan-cancer, NGS tumor profiling diagnostic panel to guide oncology treatment decision-making.

MEDIAN Technologies, Microsoft Collaborate
Friday, July 01, 2016
Collaboration aims to develop new cancer detection, diagnosis and monitoring methods using Big Data analytics.

New CAR T Cell Therapy Using Double Target Aimed at Solid Tumors
Friday, July 01, 2016
Researchers at Penn University have described how antibody, carbohydrate combination could apply to range of cancer types.

New Nanoparticle Technology Developed to Treat Aggressive Thyroid Cancer
Friday, July 01, 2016
Researchers from Brigham and Women’s Hospital have developed a nanoplatform that can deliver RNAi agents to sites of anaplastic thyroid cancer.

<< 5 6 7 8 9 10 11 >>
Showing Results 71 - 80 of 4223
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!